Q32 Bio (QTTB) Return on Equity (2018 - 2026)

Q32 Bio has reported Return on Equity for 9 years, with the latest figure at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity rose 71.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 71.0% YoY), and the FY2025 full-year result was 0.01%, up 1.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.01%, down from 0.03% in the prior quarter.
• The five-year high for Return on Equity was 0.06% in Q2 2025, with the low at 0.7% in Q1 2025.
• Average Return on Equity over 5 years is 0.04%, with a median of 0.0% recorded in 2023.
• Year-over-year, Return on Equity slumped 71 bps in 2025 and jumped 71 bps in 2026.
• Tracing QTTB's Return on Equity over 5 years: stood at 0.0% in 2022, then surged by 936 bps to 0.0% in 2023, then slumped by 1315 bps to 0.04% in 2024, then surged by 166 bps to 0.03% in 2025, then slumped by 70 bps to 0.01% in 2026.
• The last three Return on Equity figures came in at 0.01% (Q1 2026), 0.03% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.

Peer Comparison